Quest PharmaTech Inc. (TSXV:QPT)
Canada flag Canada · Delayed Price · Currency is CAD
0.0400
+0.0100 (33.33%)
At close: Feb 9, 2026

Quest PharmaTech Balance Sheet

Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Jan '25 Jan '24 Jan '23 Jan '22 Jan '21
Cash & Equivalents
0.060.210.720.370.260.2
Cash & Short-Term Investments
0.060.210.720.370.260.2
Cash Growth
-68.75%-71.39%91.36%41.73%32.76%-91.88%
Other Receivables
--0.10.2200.03
Receivables
--0.10.2200.03
Prepaid Expenses
0.030.020.020.030.020.05
Total Current Assets
0.080.230.840.620.290.28
Property, Plant & Equipment
---00.020.06
Long-Term Investments
24.2422.3323.6326.1790.71175.27
Other Long-Term Assets
0.010.010.010.010.010.01
Total Assets
24.3322.5624.4826.891.03175.61
Accounts Payable
0.170.10.280.080.110.09
Accrued Expenses
0.080.060.040.03--
Short-Term Debt
11110.50.25
Current Portion of Leases
----0.010.04
Total Current Liabilities
1.251.171.321.110.620.38
Long-Term Leases
-----0.01
Total Liabilities
1.251.171.321.110.620.39
Common Stock
30.7430.7430.7430.7430.6230.62
Additional Paid-In Capital
11.7711.6911.611.1311.0610.79
Retained Earnings
-19.29-20.88-19.08-16.0648.78133.81
Comprehensive Income & Other
-0.14-0.15-0.11-0.11-0.05-
Total Common Equity
23.0821.423.1525.790.41175.22
Shareholders' Equity
23.0821.423.1525.790.41175.22
Total Liabilities & Equity
24.3322.5624.4826.891.03175.61
Total Debt
11110.510.3
Net Cash (Debt)
-0.94-0.79-0.28-0.63-0.25-0.11
Net Cash Per Share
-0.01-0.00-0.00-0.00-0.00-0.00
Filing Date Shares Outstanding
169.13169.13169.13169.13168.24168.24
Total Common Shares Outstanding
169.13169.13169.13169.13168.24168.24
Working Capital
-1.17-0.94-0.49-0.48-0.33-0.09
Book Value Per Share
0.140.130.140.150.541.04
Tangible Book Value
23.0821.423.1525.790.41175.22
Tangible Book Value Per Share
0.140.130.140.150.541.04
Machinery
---0.550.60.6
Leasehold Improvements
----0.010.01
Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.